ATS and Spirax Group Compared in Financial Analysis

Analysts see more upside potential in ATS stock compared to Spirax Group

Feb. 25, 2026 at 9:50am

Got story updates? Submit your updates here. ›

A financial analysis comparing industrials companies ATS (NYSE:ATS) and Spirax Group (OTCMKTS:SPXSY) found that ATS has stronger profitability metrics, higher institutional ownership, and more favorable analyst recommendations than Spirax Group. While Spirax Group has higher earnings per share, ATS is seen as having greater potential upside according to analysts.

Why it matters

This analysis provides investors with a detailed comparison of two industrial companies, highlighting their relative strengths and weaknesses across key financial metrics. Understanding these differences can help investors make more informed decisions about which stock may be the better investment option.

The details

The analysis found that ATS has higher net margins, return on equity, and return on assets compared to Spirax Group. ATS also has higher revenue but lower earnings per share than Spirax Group. Analysts currently have a consensus target price of $35 for ATS, indicating a potential upside of 7.88%, compared to Spirax Group. Additionally, ATS has higher institutional ownership at 75.8% versus just 0.4% for Spirax Group.

  • The analysis was published on February 25, 2026.

The players

ATS Corporation

A global provider of automation solutions for various industries, including life sciences, transportation, and consumer products.

Spirax Group

A British engineering company that provides steam, electrical, and fluid technology solutions to a range of sectors.

Got photos? Submit your photos here. ›

The takeaway

This analysis highlights the relative strengths of ATS compared to Spirax Group, with ATS showing stronger profitability metrics, higher institutional backing, and more favorable analyst sentiment. Investors looking to gain exposure to the industrials sector may want to consider ATS as a potential investment option based on these findings.